期刊文献+

免疫增强透射比浊法测定超敏C-反应蛋白的方法学评价 被引量:10

Particle enhanced immunoturbidimetic assay of high sensitive C-reactive protein
下载PDF
导出
摘要 目的 :对免疫增强透射比浊法在全自动生化分析仪上测定超敏C 反应蛋白 (Hs CRP)的方法进行评价。方法 :检测该方法的分析范围、最低检测限、精密度、抗干扰能力及参考范围。结果 :免疫增强透射比浊法测定Hs CRP的分析范围为 0 .12 5~ 12 .5mg/L ,最低检测限为 0 .115mg/L ,批内、批间精度分别为 0 .89%和0 .90 %;本实验室Hs CRP的参考范围为 0 .2 0~ 2 .6 0mg/L。结论 :免疫增强的透射比浊法在全自动生化分析仪上测定Hs CRP的方法具有敏感性高、稳定性好、方便快速的优点 ,适宜于在临床推广应用。 Objective To evaluate the particle enchanced immunoturbidimetic assay of high sensitive C-reactive protein by the automated chemistry analyzer (Hitachi 7170A). Methods The detection limit of quantification,measurement range,precision,interference and reference interval were assessed.Results The measurement range of the method was from 0.125 to 12.5 mg/L.The detection limitation was 0.115 mg/L. The internal and external accuracy were 0.89% and 0.90% respectively.The reference range of the assay was from 0.20 mg/L to 2.60 mg/L.Conclusion The particle enhanced immunoturbidimetic assay is sensitive and stable, and can be used in clinical diagnosis.
出处 《湖南医科大学学报》 CSCD 北大核心 2003年第4期415-417,共3页 Bulletin of Hunan Medical University
关键词 免疫增强透射比浊法 测定 超敏C-反应蛋白 方法学评价 high sensitive protein particle enchanced immunoturbidimetic assay methodology
  • 相关文献

参考文献7

  • 1Tonari Y,Chida M,Koyama T,et al. Establishment of a reference interval for highly sensitive CRP by exclusion of individuals with abnormal values in related laboratory tests[ J ]. Rinsho Byori,2001,49(2) :178-182.
  • 2Rifai N, Tracy RP, Pidker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay[J]. Clin Chem, 1999 ,45 ( 12 ) :2136-2141.
  • 3Whicher J, Biasucci L, Rifai N. Inflammation , the acute phase response and atherosclerosis[J]. Clin Chem Lab Med, 1999,37(5) :495-503.
  • 4Schalkwijk CG, Poland DCW, van Dijk W, et al. Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical microangiopathy and correlaes with markers of endothelial dysfunction: evidence for chronic inflammation[ J ]. Diabetologia, 1999,42 ( 3 ) : 351-357.
  • 5Roberts WL, Sedrick R, Moulton L, et al. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications[ J ]. Clin Chem,2000,46(4 ) :461-468
  • 6Haverkate F, Tompson SG, Pyke SDM, et al. Production of Creactive protein and risk of coronary events in stable and unstable angina[J]. Lancet, 1997,349(4) :462-465.
  • 7Nader R, Pussell P, Paul M, et al. Clinical efficacy of automated high-sensitive C-reactive protein assay[ J ]. Clin Chem, 1999,12(12) :2136-2141.

同被引文献104

引证文献10

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部